Nabsys Expands Leadership Team to Prepare for Commercialization of Novel DNA Positional Sequencing Technology
Point Judith portfolio company Nabsys, Inc. has initiated its transition from technology development to product commercialization by announcing the appointment of Stand Rose, Ph.D., as the company’s first chief commercial officer. Nabsys is also announcing that Jeffrey Sklar, M.D., Ph.D., has agreed to join the company’s scientific advisory board.